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ABSTRACT: Characterization of the assembly of lipoprotein(a) [Lp(a)] is of fundamental importance to 
understanding the biosynthesis and metabolism of this atherogenic lipoprotein. Since no established cell 
lines exist that express Lp(a) or apolipoprotein(a) [apo(a)], a “transferrinfection” system for apo(a) was 
developed utilizing adenovirus receptor- and transferrin receptor-mediated DNA uptake into cells. Using 
this method, different apo(a) cDNA constructions of variable length, due to the presence of 3, 5, 7 ,9 ,  15, 
or 18 internal kringle IV sequences, were expressed in cos-7 cells or C H O  cells. All constructions contained 
kringle IV-36, which includes the only unpaired cysteine residue (Cys-4057) in apo(a). r-Apo(a) was 
synthesized as a precursor and secreted as mature apolipoprotein into the medium. When medium containing 
r-apo(a) with 9, 15, or 18 kringle IV repeats was mixed with normal human plasma LDL, stable complexes 
formed that had a bouyant density typical of Lp(a). Association was substantially decreased if Cys-4057 
on r-apo(a) was replaced by Arg by site-directed mutagenesis or if Cys-4057 was chemically modified. 
Lack of association was also observed with r-apo(a) containing only 3, 5, or 7 kringle IV repeats without 
“unique kringle IV Sequences”, although Cys-4057 was present in all of these constructions. Synthesis and 
secretion of r-apo(a) was not dependent on its sialic acid content. r-Apo(a) was expressed even more 
efficiently in sialylation-defective C H O  cells than in wild-type C H O  cells. In transfected C H O  cells defective 
in the addition of N-acetylglucosamine, apo(a) secretion was found to be decreased by 50%. Extracellular 
association with LDL was not affected by the carbohydrate moiety of r-apo(a), indicating a protein-protein 
interaction between r-apo(a) and apoB. These results show that, besides kringle IV-36, other kringle IV 
sequences are necessary for the extracellular association of r-apo(a) with LDL. Changes in the carbohydrate 
moiety of apo(a), however, do not affect complex formation. 
Lipoprotein(a) [Lp(a)] is currently the subject of intensive 
investigation because elevated plasma concentrations of Lp- 
(a) represent an independent risk factor for myocardial 
infarction and stroke (Scanu & Fless, 1990; Utermann, 1989, 
1990; Edelberg & Pizzo, 1991). Despite its clinical impor- 
tance, the physiological function of Lp(a) is unknown. 
Structurally, Lp(a) resembles a low-density lipoprotein (LDL) 
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particle with apolipoprotein (apo) B-100 and apo(a) as major 
structural protein constituents. Biochemical evidence suggests 
a direct linkage of apo(a) to apoB by a disulfide bridge 
(Sommer et al., 1991; Guevara et al., 1993). A single free 
cysteine residue on apo(a) corresponding to Cys-4057 on the 
published apo(a) cDNA sequence is believed to be involved 
in this heterodimer formation (McLean et al., 1987). Apo(a) 
is a glycoprotein with a high sialic acid content that shares 
extensive protein sequence homology with plasminogen 
(McLean et al., 1987). This homology includes the presence 
of sequences similar to kringle IV, kringle V, and the protease 
domain of plasminogen on apo(a). The genes for plasminogen 
and apo(a), together with two apo(a) pseudogenes, are located 
within a gene cluster on chromosome 6 (Ichinose, 1992; 
Malgaretti et al., 1992). At least 30 apo(a) alleles exist in 
humans, which determine proteins of variable size (Lackner 
et al., 1991; Kamboh et al., 1991). These size differences are 
due to variation in the number of kringle IV repeats on apo(a) 
(Kraft et al., 1992). In Caucasians, as well as in the 
cynomologous monkey model, Lp(a) plasma concentrations 
are known to be partially determined by the number of kringle 
IV repeats on the apo(a) gene (Kraft et al., 1992; Boerwinkle 
et al., 1992; Utermann et al., 1990; Koschinsky et al., 1990; 
Azrolan et al., 1991). 
Apo(a) and apoB are both produced in the liver. Metabolic 
studies in humans have demonstrated that triglyceride-rich 
lipoproteins, which are well-established precursors of LDL, 
do not represent metabolic precursors for Lp(a) (Krempler 
et al., 1979; Sandholzer et al., 1992). The question of whether 
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apo(a) forms a complex with apoB in hepatocytes or whether 
apo(a) binds to LDL only after its secretion to the interstitium 
or the plasma compartment remains open. Evidence has been 
found that free apo(a) can be secreted from liver cells. Free 
apo(a) is detectable in the plasma of patients suffering from 
abetalipoproteinemia (Menzel et al., 1990). In transgenic 
mice that overexpress human apo(a), the apolipoprotein is 
found at high concentrations in the plasma of the animals, 
despite its inability to associate with mouse LDL to form 
Lp(a) (Chiesa et al., 1992). Finally, when r-apo(a) was 
expressed in transfected Hep G2 cells a large amount of r-apo- 
(a) was found in its free, non-apoB-associated form (Ko- 
schinsky et al., 1991). Evidence supporting an extracellular 
association between apo(a) and LDL was obtained when the 
injection of human LDL into transgenic mice expressing 
human apo(a) resulted in the rapid and efficient formation 
of r-apo(a)/LDL complexes which were resistant to SDS and 
strongly resembled Lp(a) (Chiesa et al., 1992). Lp(a)-like 
particles were also found in transgenic mice expressing human 
apo(a) togetherwith human apoB (Lintonet al., 1993). Finally, 
several authors reported a strong binding affinity of recom- 
binant apo(a) [r-apo(a)] or apo(a) produced in primary baboon 
liver cells to LDL in vitro (White et al., 1993; Trieu, 1991; 
Phillips et al., 1993; Koschinsky et al., 1993). Two recent 
studies utilizing site-directed mutagenesis demonstrated the 
direct involvement of Cys-4057 in the association process 
(Koschinsky et al., 1993; Brunner et al., 1993). 
Here we report the development of a system for the efficient 
expression of free r-apo(a) in cos-7 cells and different CHO 
cell lines. Using this system it was possible to investigate the 
extracellular association of r-apo(a) of varying sizes with LDL, 
the function of the carbohydrate moiety of r-apo(a) in this 
process, and the consequences of modifications of Cys-4057 
for the extracellular binding of r-apo(a) to LDL. 
EXPERIMENTAL PROCEDURES 
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Materials and Cell Lines. DMEM (Dulbecco’s minimum 
essential medium) was obtained from Boehringer Mannheim 
(Germany), and culture dishes were from Nunc (Roskilde, 
Denmark). All cells lines used were obtained from the 
American Type Culture Collection. Cos-7 are SV40 trans- 
formed African green monkey kidney cells (ATCC CRL 
1651). CHO (Chinese hamster ovary) cell lines included a 
wild-type cell line (Pro-5-, ATCC CRL 1781), a line with 
blocked N-linked glycosylation (Lec 1, ATCC CRL 1735), 
a cell line with drastically decreased protein sialylation (Lec 
2, ATCC CRL 1736), and a cell line with UDP-galactose 
deficiency in the Golgi apparatus (Lec 8, ATCC CRL 1737). 
Anti-apo(a) and anti-apoB antibodies were produced in our 
own laboratories as described previously (Kraft et al., 1988). 
Horseradish peroxidase-linked protein A and an enhanced 
chemiluminscent detection kit (ECL kit) were obtained from 
Amersham Corp. Standard solutions for phenotyping apo(a) 
isoforms were purchased from Immuno AG (Vienna, Austria). 
Monensin was from Sigma (St. Louis, MO). Replication- 
defective biotinylated adenovirus (dI 3 12) in 40% glycerol, 
streptavidin-polylysine conjugate and human transferrin- 
polylysine conjugate in HBS buffer (20 mM HEPES, pH 7.3, 
and 150 mM NaC1) were produced at the Institute of 
Molecular Pathology, Vienna (Wagner et al., 1990). 
Construction of Apo(a) Expression Vectors. Apo(a) 
expression plasmids containing DNA sequences coding for 3, 
5 ,  7, 9, 15, and 18 kringle IV-like domains, as well as the 
kringle V-like and protease-like domains, were assembled using 
several apo(a) cDNA clones reported by McLean et al. (1987). 
Standard recombinant DNA techniques were followed (Sam- 
Frank et al. 
brook et al., 1989). Specific apo(a) cDNA fragments (see 
below) were ligated into the EcoRI site of pSG 5. This 
expression vector contains the simian virus (SV 40) early 
promoter, rabbit @-globin intron 11, and the SV 40 polyade- 
nylation signal (Green et al., 1988). For transfection experi- 
ments, plasmid DNA was isolated by the alkaline lysis method 
and purified by cesium chloride density gradient ultracen- 
trifugation. 
pSG5-S contained three kringle IV-like repeats. A 298-bp 
EcoRI-BamHI fragment isolated from A 18 cDNA (McLean 
et al., 1987) encoding the 5’-untranslated region, signal 
sequence, and 216 bp of kringle IV-1 repeat of apo(a) was 
fused to a 2024-bp BamHI-EcoRI fragment isolated from 
A41 cDNA (McLean et al., 1987) encompassing the last 117 
bp of kringle IV-35, kringles IV-36 and IV-37, kringle V, 
protease domain, and 67 bp of 3’-untranslated sequence. 
pSG5-M contained nine kringle IV repeats. A 709-bp 
EcoRI-HhaI fragment from A1 8 encoding the 5’-untranslated 
region, signal sequence, kringle IV-1, and 294 bp of kringle 
IV-2 was fused to a 3641 -bp HhaI-EcoRI fragment from A41 
containing the last 48 bp of kringle IV-30, kringles IV-31 
through IV-37, kringle V, protease domain, and 67 bp of 3’- 
untranslated sequence. 
pSG5-L contained 15 kringle IV repeats. A 1735-bp 
EcoRI-HhaI fragment from A1 8 encoding the 5’-untranslated 
region, signal sequence, kringle IV repeats 1-4, and 299 bp 
of kringle IV-5 was fused to a 4669-bp fragment from A41 
encompassing the last 48 bp of kringle IV-27, kringles IV-28 
through IV-37, kringle V, protease domain, and 67 bp of 3’- 
untranslated region. 
pSG5-XL contained 18 kringle IV repeats. A 2077-bp 
EcoRI-HhaI fragment from A1 8, encoding the 5’-untranslated 
region, signal sequence, kringle IV repeats 1-5, and 294 bp 
of kringle IV-6 was fused to a 5353-bp fragment from pSG5-L 
encompassing the last 48 bp of kringle IV-3, kringle IV-4,294 
bp of kringle IV-5, the last 48 bp of kringle IV-27, kringle IV 
repeats 28-37, kringle V, protease domain, and 67 bp of 3’- 
untranslated region. 
pSG5-Arg is identical to pSG5-XL except that the unique 
free cysteine residue (Cys 4057) was replaced by Arg using 
site-directed mutagenesis. A 2.2-kbKpnI-SspI fragment was 
cloned into M13mp19 and mutagenesis was performed with 
single-stranded DNA and a mutant oligonucleotide using the 
in vitro mutagenesis kit 2.1 from Amersham. After the 
mutagenesis experiment, sequence analysis confirmed that 
the T to C base change was successfully introduced. The 
mutated DNA fragment was recloned into pSG5-XL. 
pSG5-3.0 contained five kringle IV repeats. A 982-bp 
EcoRI-BamHI fragment from A1 8 encoding the 5’-untrans- 
lated region, signal sequence, kringle IV- 1, kringle IV-2, and 
225 bp of kringle IV-3 was fused to a 2024-bp BamHI-EcoRI 
fragment isolated from A41 encompassing the last 1 17 bp of 
kringle IV-35, kringle IV-36, kringle IV-37, kringleV, protease 
domain, and 67 bp of 3’-untranslated region. 
pSG5-3.6 contained seven kringle IV repeats. A 1963-bp 
EcoRI-PstI fragment was isolated from A18 encoding the 
5’-untranslated region, signal sequence, kringle IV repeats 
1-5, and 184 bp of kringle IV-6 was fused to a 1726-bp PstI- 
EcoRI fragment from A41 encompassing the last 158 bp of 
kringle IV-36, kringle IV-37, kringle V, protease domain, and 
67 bp of 3’-untranslated region. 
Cell Culture and Transfection of Cultured cos-7 and CHO 
Cells. cos-7 cells were cultured in DMEM, supplemented 
with 10% fetal calf serum (FCS) or 10% lipoprotein-depleted 
human serum (LPDS). CHO cells (Pro 5-) andglycosylation- 
defective CHO cell lines (Lec 1, Lec 2, and Lec 8) were cultured 
Extracellular Association of Apo(a) with LDL 
in a-MEM supplemented with 10% FCS or LPDS. cos-7 
cells were plated 24 h and CHO cells 48 h prior to DNA 
transfection in P60 dishes. Cell density reached approximately 
300 000 cells/dish at  the time of transfection. 
To obtain a high efficiency of transfection with the large 
plasmids, cells were transfected by a receptor-mediated gene 
delivery system (Zatloukal et al., 1992; Cotten et al., 1992). 
A streptavidin-polylysine conjugate was diluted in HBS buffer 
(20 mM HEPES, pH 7.3, and 150 mM NaC1) to a total 
volume of 100 pL and mixed with biotinylated adenovirus 
diluted in 100 pL of HBS buffer. The mixture was incubated 
for 30 min at room temperature and mixed with 6 pg of DNA 
in 150 pL of HBS. After 30 min at room temperature, the 
transferrin-polylysine conjugate in 150 pL of HBS was added 
and incubated again for 30 min at room temperature. The 
total mix of 500 pL was added to 1.5 mL of cell medium 
supplemented with 2% FCS or LPDS and added to precon- 
fluent cells. After 4 h the transfection mixture was replaced 
by fresh DMEM supplemented with 10% FCS or 10% LPDS. 
The amounts of streptavidin-polylysine and transferrin- 
polylysine conjugate depended strongly on the adenovirus 
preparation and was optimized for each virus batch used in 
transfection experiments. For optimization of transfection 
condition and for normalization of transfection efficiencies, 
expression plasmids for @-galactosidase (McGregor & Caskey, 
1989) and human growth hormone (Selden, 1987) were 
cotransfected by the same method in some experiments. 
/3-Galactosidase assays were performed according to standard 
techniques (Sambrook et al., 1989). The radioimmunoassay 
for human growth hormone was purchased from BSM 
Diagnostics (Vienna, Austria) and the protocol of the 
manufacturer was followed. 
Inhibition of Glycosylation in the Golgi Complex of 
Transfected Cos-7 Cells. To investigate glycosylation within 
the Golgi compartment, transfected cos-7 cells were treated 
with monensin, an inhibitor of protein transport within the 
Golgi complex (Griffiths et al., 1983). Monensin (1 pM) was 
added to the cell medium and cells were cultivated for an 
additional 12 h. After incubation, the cell medium was 
collected, cells were harvested, and cell lysates were prepared 
as described below. 
Recombinant Apo(a) Analysis in Cell Media and Cell 
Lysates. At various times following transfection, cell medium 
and cell lysates were analyzed for the presence of r-apo(a). 
Once the medium was aspirated, a mixture of proteinase 
inhibitors was added to avoid r-apo(a) degradation (0.2 pM 
aprotinin, 50 pM leupeptin, and 1 pM PMSF). Free-floating 
cells were removed by centrifugation for 10 min at 2000g and 
samples were immediately analyzed or stored at -70 OC. For 
the analysis of intracellular r-apo(a), cell lysates were prepared. 
Cells were washed twice with ice-cold phosphate-buffered 
saline (PBS), scraped off the culture dishes using a rubber 
policeman and 1 mL of lysis buffer (1% Triton X-100,50 mM 
HEPES, pH 7.2, 150 mM NaCl, 0.5 mM EDTA, and 0.5 
mM EGTA), and transferred to a centrifuge tube. After 
incubation for 30 min on ice, cellular debris was removed by 
centrifugation at 13000g for 2 h. Supernatants were further 
analyzed. For r-apo(a) analysis, cell medium and lysates 
were diluted (1:l ratio) with SDS electrophoresis running 
buffer (0.1% bromophenol blue, 1% glycerol, and 2% SDS) 
in the presence (reducing conditions) or absence (nonreducing 
conditions) of 5% @-mercaptoethanol. Samples were heated 
for 5 min at 100 OC, cooled down to room temperature, and 
subjected to SDS-agarose gel electrophoresis or SDS-PAGE. 
SDS-agarose gel electrophoresis was performed according to 
the method described by Kamboh et al. (1991). Briefly, the 
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gel contained 1.5% ultrapure agarose (Gibco Ltd., England) 
in 90 mM Tris-borate buffer, pH 7.4, 2 mM EDTA, and 
0.1% SDS. Electrophoresis was carried out in a submarine 
agarose gel unit using 45 mM Tris-borate buffer, pH 7.4, 
0.1% SDS, and 2 mM EDTA as running buffer. After 
electrophoresis, proteins were transferred to a nitrocellulose 
membrane by electroblotting using an LKB 2005 transport 
power supply with a 2219 thermostatic circulator overnight 
at 4 "C in 10 mM Tris and 40 mM glycine buffer, pH 7.4. 
SDS-PAGE of r-apo(a) containing samples and subsequent 
immunoblotting was performed essentially as described earlier 
(Utermann et al., 1987). Briefly, samples were heated for 3 
min at 95 OC in a solution of 5% SDS and 0.02 mM 
ethylmorpholine, pH 8.6, in the presence (reducing conditions) 
or absence (nonreducing conditions) of 5% P-mercaptoethanol. 
A 5-pL aliquot was applied to a 6.6% polyacrylamide gel and 
run in a 10 X 10-cm electrophoresis chamber from Biometra 
(GBttingen, Germany). 
Zmmunodetection of r-Apo(a), After protein transfer, the 
nitrocellulose membrane was incubated for 60 min in a solution 
of 5% powdered skim milk in Tris-buffered saline, pH 7.4 
(TBS), to block the remaining unspecific protein-binding sites. 
The membrane was then incubated for 3 h with a rabbit anti 
human apo(a) (K202, K271) or anti-apoB antiserum at a 
dilution of 1 : 1000, washed extensively in TBS containing 0.05% 
Tween 20, and incubated with horseradish peroxidase-labeled 
protein A as a second antibody for 3 h. After repetitive washing 
(see above), the membrane was incubated with the ECL 
Western blotting detection reagent for 1 min and subjected 
to autoradiography. Immunoblotting after SDS-PAGE was 
performed identically, except that in some experiments a 
monoclonal apo(a) antibody (clone 1A2) was used for detection 
(Kraft et al., 1988). In that case a goat anti-mouse 
immunoglobin conjugated with horseradish peroxidase was 
used as second antibody. Identical conditions were used when 
a monoclonal antibody specific for kringle V sequences of 
apo(a) was employed for immunodetection (Huby et al., 1994). 
Immunoquantitation of r-Apo(a) and Apo B. r-Apo(a) 
quantitation in cell culture media and fractions thereof was 
performed with a double-antibudy ELISA as described earlier 
(Menzel et al., 1990). Affinity-purified polyclonal anti-apo(a) 
antibody was used for coating the ELISA plates, and the 
horseradish peroxidase-labeled monoclonal antibody 1 A2 was 
used for detection (Selden, 1987). This antibody does not 
cross-react with plasminogen. A commercially available Lp(a) 
standard from Immuno AG (Vienna, Austria) served as a 
control. Concentrations of apoB in cell media and ultracen- 
trifugation density gradient fractions were measured by a 
recently described double-antibody ELISA (Dieplinger et al., 
1993). An affinity-purified rabbit polyclonal antibody against 
human apoB was used for coating. The same antibody was 
horseradish peroxidase-labeled and used as the detection 
antibody for apoB in samples and standard. A calibrated 
standard in a dilution series from 1:700 to 1:240.000 served 
as secondary standard (calibration serum apolipoprotein, 
Boehringer Mannheim, Germany). 
Association of r-Apo(a) with Human LDL. LDL was 
prepared by ultracentrifugation in a density range from 1.020 
to 1.63 g/mL from plasma obtained from healthy subjects as 
previously described (Zechner et al., 1984). All subjects were 
Lp(a)-negative in our immunoassay, and LDL fractions were 
additionally subjected to immunoabsorption chromatography 
on an anti-apo(a)-Sepharose column to remove any con- 
taminating Lp(a). All LDL fractions were tested in Western 
blot analysis for the complete absence of Lp(a). To avoid 
LDL oxidation, all steps of LDL preparation were performed 
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under nitrogen and in the presence of 0.5 mg/mL EDTA. In 
dose-response experiments, increasing concentrations of LDL 
(1,5, and 10 pg/mL LDL protein) were added to 0.4 mL of 
2X concentrated medium containing r-apo(a) at a concentra- 
tion of approximately 0.5-1.0 nM. Incubations were per- 
formed for 24 h at 37 OC in the presence of aprotinin, leupeptin, 
and PMSF as protease inhibitors. In time course experiments, 
0.4 mL of medium was incubated under conditions identical 
to those mentioned above with 5 pg/mL LDL protein. 
Aliquots from the association incubation were removed at 
various times and analyzed for r-apo(a)/LDL complex 
formation by Western blotting. To study the influence of the 
presence of cells on the association process, dose-response 
experiments were also performed directly in the tissue culture 
plates. LDL protein (1,5, and 10 pg/mL) was added in two 
equivalent doses, 2 and 16 h after transfection, to 3 mL of 
r-apo(a)-containing medium. After an additional 8 h of 
incubation, the media were concentrated to half the volume 
by a Speed-Vac (Savant). r-Apo(a)/LDL complexes were 
visualized by immunoblotting after SDS-agarose gel elec- 
trophoresis or SDS-PAGE. In some experiments the as- 
sociation mixture contained potential inhibitors of complex 
formation. These included iodoacetamide, SDS, n-octyl 
glucoside, e-aminocaproic acid, and NaC1. Depending on the 
protein concentration, iodoacetamide was added at  a con- 
centration of 50-250 mg/mL directly to LDL or r-apo(a)- 
containing medium. After an overnight incubation, free 
iodoacetamide was removed by gel filtration and the alkylated 
fractions were used in association experiments as described 
above. The other “inhibitors” were directly added at two 
different concentrations to the association mixture or 4 h after 
the association experiment was started. 
Immunoquantitation of r-Apo(a) in r-Apo(a)/LDL Com- 
plexes. A double-antibody DELFIA was developed for the 
quantitation of r-apo(a) specifically bound to LDL after 
association experiments. DELFIA assays were performed 
according to the fluorescence immunoassay from Pharmacia 
(Uppsala, Sweden). Multiwell DELFIA plates were coated 
with a polyclonal affinity-purified antibody directed against 
human plasma LDL that did not cross-react with Lp(a) or 
apo(a). After nonspecific binding sites were blocked with 
250 pL of 0.5% bovine serum albumin, 200-pL aliquots of 
sample volume from the association mixtures were added to 
the wells. Samples were incubated for 2 h at ambient 
temperature and washed several times with DELFIA buffer 
(50 mM Tris-HC1, pH 7.7). For detection, an Eu-labeled 
polyclonal antibody against human Lp(a) (K202) was added, 
and the plates were again incubated for 2 h at ambient 
temperature. Excess antibody was removed by washing the 
plates with DELFIA buffer and 200 pL of enhancement 
solution were added according to the protocol supplied by the 
manufacturer. Fluorescence was determined after 15 min in 
a DELFIA reader. An Lp(a) standard (Immuno AG, Vienna, 
Austria) was included in all experiments, and the assay was 
found to be linear between 1 and 100 ng of Lp(a)/well. To 
determine the total apo(a) concentration in the association 
mixtures, DELFIA assays were performed under the identical 
conditions except that the anti-Lp(a) antibody was also used 
for coating the plates. 
Density Gradient Ultracentrifugation of r-Apo(a)-LDL 
Complexes. For separation of LDL-associated r-apo(a) from 
free r-apo(a), ultracentrifugation on a salt density gradient 
was performed according to Chung et al. (1980) with slight 
modifications. Cell culture medium (4 mL) was brought to 
a density of 1.21 g/mL by addition of solid KBr and layered 
under 9 mL of an 0.15 M NaCl solution in Quickseal 
Frank et al. 
centrifugation tubes (Beckman, Palo Alto, CA). Centrifuga- 
tion was carried out in a vertical rotor (Beckman VTi 65) at 
4 OC at 65 000 rpm for 90 min. The densities of the fractions 
were estimated by measuring the refractive index. After 
ultracentrifugation, gradient fractions were dialyzed and 
analyzed for apo(a) and apoB. 
RESULTS 
Transferrinfection of Apo(a) cDNA Constructions. Figure 
1 exhibits the apo(a) cDNA constructions used for transfer- 
rinfection in cos-7 cells. All clones contained the 5’-UTR, 
the coding region for the signal peptide, the kringle V domain, 
and the proteasedomain, as well as the 3’-UTR. Additionally, 
the different clones contained 3 (pSG5-S), 9 (pSG5-M), 15 
(pSG5-L), and 18 (pSG5-XL) kringle IV repeats. In some 
experiments two additional constructions were used which 
are designated pSG5-3.0 and pSG5-3.6. Kringle IV-36 with 
the unique unpaired Cys-4057 and kringle IV-37 were present 
in all constructions. All apo(a) cDNA sequences were cloned 
into pSG5, a eukaryotic expression vector under the control 
of the SV 40 promoter. After transferrinfection of these clones 
into preconfluent cos-7 cells, cell lysates and cell media were 
analyzed for the presence of r-apo(a) by SDS-agarose gel 
electrophoresis or SDS-PAGE and immunochemical detection 
using plyclonal antisera specific for apo(a). Peptides resulting 
from transfection of cells with plasmids pSG5-S, pSG5-M, 
pSG5-L, and pSG5-XL are designated r-apo(a)-S, r-apo(a)- 
M, r-apo(a)-L, and r-apo(a)-XL, respectively. The two 
additional peptides derived from pSG5-3.0 and pSG5-3.6 are 
designated r-apo(a)-3.0 and r-apo(a)-3.6. 
Generally, high concentrations of adenovirus in the trans- 
ferrinfection mixture increased the amount of r-apo(a) 
synthesized and secreted by the cells. However, high virus 
titers also caused cell death. Therefore, the influence of the 
virus concentration in the transferrinfection procedure was 
optimized with regard to cell viability and transfection 
efficiency. Control transfections with @-galactosidase expres- 
sion plasmids and subsequent enzyme assays revealed that, 
under the conditions used in these studies, between 30% and 
50% of the cells received plasmid DNA. At these transfection 
efficiencies, r-apo(a) synthesis and secretion was found to 
range from 4 to 10 pg cell-’ (24 h)-l over a time period of 48 
h, as quantitated by apo(a) ELISA. Time course experiments 
of r-apo(a)-L secretion after transferrinfection of pSG5-L 
into cos-7 cells revealed the highest expression of r-apo(a)-L 
2 days after transferrinfection after normalization to the total 
cellular DNA concentrations per dish. After that time point, 
synthesis and secretion declined. 
Figure 2 displays an immunoblot after SDS-PAGE under 
nonreducing conditions of r-apo(a) from lysates and media of 
transfected cos-7 cells. The signal obtained from r-apo(a)-S 
was weak and only detectable in the cell medium when the 
polyclonal antiserum K27 1 was used for immunodetection 
(Figure 2A). Strong bands, however, were obtained for the 
r-apo(a)-M-, r-apo(a)-L-, and r-apo(a)-XL-expressing con- 
structions (Figure 2B). Two intracellular r-apo(a) signals of 
different molecular weight were present. Only a single band 
was detected in the cell medium, which corresponded to the 
high molecular weight intracellular form. To test if the smaller 
intracellular r-apo(a) signal represented an r-apo(a) precursor, 
pSG5-L transfected cells were treated with monensin. This 
antibiotic inhibits protein transport within the Golgi apparatus, 
leaving r-apo(a) only glycosylated to the extent that glyco- 
sylation occurred in the endoplasmic reticulum. When 
analyzed by SDS-PAGE and immunoblotting, intracellular 
r-apo(a)-L from monensin-treated cells exhibited the same 
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FIGURE 1 : Apo(a) cDNA constructions used for transferrinfection. All constructions are compared to the apo(a)-cDNA structure published 
by McLean et al. (1987). All clones include the 5' UTR, the coding region for the signal peptide (S), the kringle V domain (V), the protease 
domain (P), the 3' UTR, and variable numbers of kringle IV repeats. The kringle IV repeats in each construction are numbered and labeled 
according to their structural characteristics as A repeats, B repeats, or unique sequence repeats as suggested by McLean et al. (1987). Fused 
kringle IV repeats are also indicated (F). pSG5-Arg had the identical structure as pSG5-XL except that a single free cysteine residue in kringle 
IV-36 (Cys-4057) was replaced by arginine using site-directed mutagenesis. 
molecular weight as the smaller, intracellular isoform from 
untreated cells (Figure 2C). This suggested that the smaller 
protein within transfected cos-7 cells represented a partially 
glycosylated or unglycosylated precursor protein. 
The molecular sizes of intra- and extracellular protein bands 
increased with the number of kringle IV sequences within 
apo(a) cDNA constructions. The smallest clone yielded a 
mature protein with an apparent molecular mass of ap- 
proximately 300 kDa, whereas the largest construction with 
18 kringle IV sequences yielded an apparent molecular mass 
of 550 kDa. No obvious differences were observed with regard 
to signal intensity among r-apo(a)-M, r-apo(a)-L, and r- 
apo(a)-XL. However, r-apo(a)-S, with only three "unique 
sequence" kringle IV repeats, was only poorly detected by 
Western blotting using the polyclonal antiserum K27 1. To 
investigate if the poor detection of r-apo(a)-S was due to poor 
reactivity of K27 1 or a decreased expression efficiency of this 
expression plasmid, a recently developed antibody specific for 
kringle V of apo(a) (Huby et al., 1994) and a newly developed 
polyclonal antiserum (K202) were used in Western blotting 
experiments. With these reagents identical expression ef- 
ficiency was observed for r-apo(a)-S compared to the other 
clones. This suggested that the polyclonal antiserum K27 1 
was mainly directed against kringle IV sequences not present 
on r-apo(a)-S. When the monoclonal antibody 1A2 was used 
for immunoblotting or ELISA analysis, r-apo(a)-S was not 
detected at all. The binding site of this monoclonal antibody 
was recently mapped to kringle IV sequences of apo(a) which 
are not present on r-apo(a)-S (H. Dieplinger et al., submitted 
for publication). 
Synthesis and Secretion of r-Apo(a) by Glycosylation 
Mutants. To study the influence of N-glycosylation on the 
synthesis and secretion of r-apo(a), glycosylation-defective 
Chinese hamster ovary (CHO) cells (Lec 1, Lec 2, and Lec 
8) and the wild-type parental cell line of these mutant lines 
(ProS-) were transfected with pSG5-L. r-Apo(a)-L synthesis 
and secretion were then analyzed by Western blotting and 
ELISA quantitation. In preliminary experiments it was 
established that the lack of carbohydrates or sialic acid does 
not change the immunoreactivity of the polyclonal antiserum 
or the monoclonal antibody 1A2 used in these studies (H. J. 
Menzel and G. M. Kostner, personal communication). Lec 
1 cells lack glycosyltransferase T1 so that N-linked carbo- 
hydrate addition is blocked at the Man5GlcNAc2Asn inter- 
mediate (Stanley et al., 1975). Lec 2 cells exhibit a drastic 
reduction in the transport of CMP-sialic acid into the Golgi 
compartment, resulting in severely decreased sialylation of 
proteins (Deutscher et al., 1984). Lec 8 cells exhibit a drastic 
reduction in the ability to transport UDP-galactose into the 
Golgi compartment (Deutscher 8c Hirschberg, 1986). To 
provide these experiments with an internal control for 
transfection efficiencies, pSG5-L was cotransfected with a 
human growth hormone expression plasmid, pGH. Human 
growth hormone is not glycosylated, and therefore, its 
expression is not influenced by the glycosylation defects in the 
CHO cell lines used. Table 1 summarizes the results. 
Compared to the wild-type CHO cell line, Pro 5-, Lec 1 cells 
secreted 55.6%f 9.4%asmuchr-apo(a)-Lwhen theexpression 
was normalized to growth hormone expression. This indicated 
that addition of NAcGlc was important for proper apo(a) 
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Table 1:  Secretion of r-Apo(a)-L into the Medium of Transfected 
Glycosylation Defective CHO Cell Lines" 
cell hGHC apo(a)d apo(a) 
cell line6 number (cpm) (ng/mL) (%fSD)  
Pro 5- (wild type) 370 000 11 282 733 100 
Lec 1 464000 10 172 438 55.6f9.4 
Lec 2 460 000 10 379 1050 15 1.9 f 66.4 
Lec 8 459000 10708 583 89.2 f 25.8 
Wild-type and glycosylation-defective CHO cells were transfected 
with pSG5-L and the secretion of apo(a) into the medium after incubation 
for 24 h was measured by ELISA. Results of one representative 
experiment are shown. The amount of apo(a) secreted from mutant cells 
in relation to Pro5- (percent) was calculated from four separate 
experiments. Lec 1, lack of glycosyltransferase T1; Lec 2, decreased 
sialic acid addition; Lec 8, decreased galactose addition. E Human growth 
hormone expression served as internal control for transfection efficiencies. 
Apo(a) concentrations are normalized to hGH activities. 
secretion. Unexpectedly, transfected Lec 2 cells secreted 
151.9% f 66.4% as much of r-apo(a)-L compared to the 
expression in Pro 5- cells, suggesting that addition of sialic 
acid as a last step in carbohydrate modification was not 
necessary for the efficient secretion of r-apo(a). Lec 8 cells 
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FIGURE 3: Extracellular association of r-apo(a) of variable length 
with human plasma LDL. (A) cos-7 cells were transfected with 
pSG5-S, pSG5-M, pSG5-L, and pSG5-XL. (B) cos-7 cells were 
transfected with pSG5-S, pSG5-3.0, pSG5-3.6, and pSG5-XL. In 
both experiments 5 pg/mL LDL (protein) was added in two equal 
aliquots 2 and 16 h after transfection directly to the culture dishes. 
Twenty-four hours after transfection, the cell medium was collected 
and concentrated two times in the presence of protease inhibitors. 
Aliquots of each association mixture were subjected to SDS-1.5% 
agarose gel electrophoresis under nonreducing conditions. After 
protein transfer to nitrocellulose filters, apo(a)-specific bands were 
visualized using a rabbit anti-human apo(a) antiserum (K202) and 
an enhanced chemiluminescent detection system. The positions of 
free apo(a) and apo(a)-apoB complexes are indicated on the left. To 
estimate the molecular sizes of the bands, an apo(a) size standard 
was included (St) and is labeled on the right. 
expressed and secreted similar levels of r-apo(a)-L as wild- 
type Pro 5- cells. 
r-Apofa) Binding to LDL. An important objective of this 
study was to investigate the ability of r-apo(a) to bind to 
LDL. Therefore, extracellular association of r-apo(a) of 
variable sizes and carbohydrate contents to human plasma 
LDL was analyzed in an in vitro incubation system 24 h after 
transferrinfection. Before association experiments were 
conducted, the concentration of r-apo(a) was quantitated by 
ELISA. Freshly prepared human LDL at different concen- 
trations was added directly to the culture plates or to the 
medium after it was removed from the cells. Association of 
r-apo(a) with LDL was analyzed at different time points by 
agarose gel electrophoresis and immunoquantitation, as well 
as density gradient ultracentrifugation. Figure 3A displays 
an immunoblot after SDS-agarose gel electrophoresis that 
indicates the complex formation of r-apo(a) of variable sizes 
with LDL under nonreducing conditions. r-Apo(a)/LDL 
complexes were identified by their retarded electrophoretic 
mobility compared to free r-apo(a). Complexes could be 
identified with specific antibodies to apo(a) or apoB. Ap- 
proximately the same amounts of complex formation was 
observed when r-apo(a)-M, r-apo(a)-L, or r-apo(a)-XL was 
incubated with human plasma LDL. In contrast, r-apo(a)-S 
containing only three kringle IV repeats did not associate 
with LDL at all. 
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Table 2: Time Course of r-Apo(a)-L/LDL Complex Formation“ 
time of 
incubation (h) 
0.25 
0.5 
2 
4 
6 
8 
16 
24 
390.8 
407.4 
396.9 
388.8 
382.0 
383.6 
384.5 
386.5 
apo-B in complex 
complex [ng/mL] formation (96) 
58.3 15 
71.7 18 
99.4 25 
127.1 33 
150.9 39 
166.0 43 
21 8.7 57 
237.3 61 
r-Apo(a)-L and apoB were quantitated by double antibody DELFIA 
analyses. 
To study the requirements of certain kringle structures for 
the complex formation with LDL in more detail, additional 
constructs were created and transfected into cos-7 cells, and 
the expressed r-apo(a) variants were used in association 
experiments. Figure 3B demonstrates that r-apo(a)-3.0, which 
contains five kringle IV “type A” structures including kringle 
IV-36 and kringle IV-37 but lacks the “unique kringle” 
sequences (kringle IV-3 1 through 3 9 ,  does not form complexes 
with LDL. A construct resulting in a r-apo(a) with seven 
kringle IV sequences including kringle IV-36 and 37 [r-apo(a)- 
3.61 but lacking the “unique kringle” structures (kringle IV- 
31 through 36) is also unable to associate with the human 
plasma LDL. 
The amount of r-apo(a)-L complexed to LDL was also 
determined directly from association mixtures by double- 
antibody DELFIA analysis. Medium obtained from cos-7 
cells transfected with pSG5-L, containing 0.4-0.8 pg/mL 
r-apo(a), was mixed with freshly prepared human plasma 
LDL and incubated for 24 h at 37 “C. The relative amount 
of r-apo(a) within r-apo(a)/LDL complexes was quantitated 
by DELFIA assays performed in duplicate. In DELFIA-1, 
anti-Lp(a) was used as coating antibody and detection 
antibody. In DELFIA-2, anti-LDL was used as coating 
antibody and anti-Lp(a) was used as detection antibody 
(described in Experimental Procedures). Therefore, DEL- 
FIA-1 quantitated the total amount of r-apo(a)-L present in 
the incubation mixture, whereas DELFIA-2 detected only 
r-apo(a)-L within r-apo(a)/LDL complexes. By this method, 
30-7596 of r-apo(a)-L was detected within the complex after 
24-h incubations, depending on the amount of apo(a) and 
LDL protein present in the mixture. 
Table 2 demonstrates the kinetics of the association between 
r-apo(a)-L and LDL. Complex formation was quantitated 
by double-antibody DELFIA analysis. Complex formation 
could be detected after 0.5 h of incubation and increased up 
to 24 h. In this experiment incubations were performed in the 
absence of cells, indicating that the presence of cells is not a 
prerequisite for complex formation. In a dose-response 
experiment, increasing amounts of freshly prepared human 
LDL were added directly to r-apo(a)-L-containing medium 
in the cell culture dishes. As demonstrated in Figure 4 more 
than 50% of r-apo(a)-L was complexed to LDL when the 
LDL was present in a 2-fold molar excess (1 pg/mL of LDL 
protein), indicating the high specificity of the process. The 
presence of 5% P-mercaptoethanol in the incubation mixture 
completely inhibited complex formation. In the absence of 
r-apo(a)-L no signals were detected, whereas in the absence 
of LDL in the incubation mixtureonly uncomplexed r-apo(a)-L 
was found when anti-apo(a) antiserum was used for immu- 
nodetection (not shown). 
To demonstrate that r-apo(a)-L was in fact lipoprotein- 
associated in the r-apo(a)/LDL complex, an association 
mixture containing 5 pg/mL LDL protein, corresponding to 
- s3 - s2 - s1 
- F  
LDL @a/ml) St 1 5 10 1 5 10 
6-mercaptoethrnol + + + - - - 
FIGURE 4: Extracellular association of r-apo(a)-L with human plasma 
LDL. cos-7 cells were transfected with pSG5-L. The indicated 
amounts of LDL (protein) were added directly to the cell culture 
dishes in two equal aliquots 2 and 16 h after transfection. Twenty- 
four hours after transfection, the cell medium was collected and 
concentrated two times in the presenceof protease inhibitors. Aliquots 
of each association mixture were subjected to SDS-1.5% agarose gel 
electrophoresis under nonreducing conditions or in the presence of 
5% /3-mercaptoethanol. After protein transfer to nitrocellulose filters, 
apo(a)-specific bands were visualized using a rabbit anti-human 
apo(a) antiserum (K27 1) and an enhanced chemiluminescent 
detection system. The positions of free apo(a) and apo(a)-apoB 
complexes are indicated on the left. To estimate the molecular sizes 
of the bands, an apo(a) size standard was included (St) and is labeled 
on the right. 
a 5:l molar excess of LDL over r-apo(a)-L, was analyzed by 
density gradient ultracentrifugation. Following fractionation 
of the gradient, r-apo(a) and apoB were quantitated in all 
samples by ELISA. Figure 5 demonstrates that r-apo(a)-L 
can be detected at a buoyant density between d = 1.08 and 
1.13 g/mL, which is typical for Lp(a). Between 20% and 
60% of r-apo(a)-L was found in the Lp(a) density region, and 
therest was detected as free r-apo(a)-L in the bottom fraction. 
These results were in good agreement with data obtained from 
DELFIA analyses. ApoB was found in a density range 
between buoyant densities d = 1.02 and 1.13 g/mL, covering 
the density region of LDL and Lp(a). In the absence of LDL, 
all r-apo(a)-L was recovered in the lipid-free bottom fraction. 
Role of the Carbohydrate Moiety of r-Apo(a) for Its 
Association with LDL. The contribution of the carbohydrate 
content of r-apo(a) to the complex formation with LDL was 
studied using glycosylation-defective Lec 1, Lec 2, and Lec 
8 cells transfected with pSG5-L. By SDS-agarose gel 
electrophoresis and immunoblotting, mixtures of free and 
complexed r-apo(a)-L were detected, which were generated 
in a 24-h incubation period (Figure 6). The apparent sizes 
of uncomplexed r-apo(a)-L differ slightly due to the differences 
in their carbohydratecontent. All of the different glycosylation 
forms of r-apo(a)-L tested formed complexes with LDL. Table 
3 summarizes the results of the double-antibody DELFIA 
analyses. The relative percentage of r-apo(a)-L associated 
with LDL increased with increasing LDL concentrations from 
40% to 60%. No significant difference in the amounts of 
r-apo(a)-L within the complexes was found for all three 
glycosylation variants when compared to wild-type r-apo(a)- 
L. This indicated that complete glycosylation of r-apo(a) 
was not a prerequisite for complex formation. 
Role of Unpaired Cys Residues on r-Apo(a) or LDL for 
Association. The functional importance of free cysteine 
residues on r-apo(a) for complex formation was studied by 
chemical modification of free cysteine residues by iodoac- 
etamide on LDL and r-apo(a), respectively. Following 
alkylation, excess iodoacetamide was removed by gel filtration, 
and normal or modified r-apo(a)-XL containing medium was 
mixed with normal or modified LDL. Figure 7 summarizes 
the results of the double-antibody DELFIA analysis. Alky- 
lation of Cys residues on LDL decreased r-apo(a)-LDL 
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FIGURE 5: Density gradient ultracentrifugation of r-apo(a)/LDL complexes. Culture medium from cos-7 cells transfected with pSG5-L 
containing 10 pg/mL LDL (protein) was fractionated by density gradient ultracentrifugation in a vertical rotor (4 OC, 65 000 rpm, 90 min). 
The concentrations of apoB (open circles) and apo(a) (closed circles) were measured by ELISA; the fraction densities (open squares) were 
determined by refractometry. Positions of VLDL, LDL, and HDL were determined by running fresh human serum in parallel. 
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FIGURE 6: Influence of the carbohydrate moiety of r-apo(a) on 
complex formation with LDL. Wild-type CHO cells (Pro?) and 
CHO cells exhibiting different defects in N-glycosylation (Lec 1, 
Lec 2, and Lec 8 cells; see Experimental Procedures) were transfected 
with pSG5-L. LDL ( 5  pg/mL protein, +LDL) was added directly 
to the cell culture dishes in two equal aliquots 2 and 16 h after 
transfection. Control plates with no LDL added (-LDL) were 
otherwise treated identically as +LDL plates. Twenty-four hours 
after transfection, the cell media were collected and aliquots were 
subjected to nondenaturing SDS-1.5% agarose gel electrophoresis. 
After protein transfer to nitrocellulose filters, apo(a)-specific bands 
were visualized using a rabbit anti-human apo(a) antiserum (K27 1) 
and an enhanced chemiluminescent detection system. The positions 
of free apo(a) and apo(a)-apoB complexes are indicated on the left. 
To estimate the molecular sizes of the bands, an apo(a) size standard 
was included (St) and is labeled on the right. 
association by 50%. If free cysteine residues were modified 
in LDL and r-apo(a)-XL, complex formation was decreased 
by more than 90%. 
To investigate if the extracellular association between 
r-apo(a) and LDL was dependent on the presence of a single 
free cysteine residue in r-apo(a) at a position corresponding 
to amino acid residue 4057 of the mature protein (McLean 
et al., 1987) this position was altered to arginine by in vitro 
mutagenesis of pSG5-XL. The presence of the correct single- 
base mutation was verified by DNA sequencing, and the 
mutated clone (pSG5-Arg) was transfected into cos-7 cells by 
transferrinfection. The expression of r-apo(a)-Arg and its 
Table 3: Influence of Apo(a) Glycosylation on the Association with 
LDLa 
amount of LDL added to the medium 
Pros- (wild type) 38 f 6 46 f 8 58 i 12 
Lecl 41 f8 5 1 f 5  60i 11 
Lecl 44 f 4 48 f 8 60f 5 
Lec8 37 f 7 43 f 4 55 f 10 
a pSG5-L apo(a) was transfected into wild-type and glycosylation- 
defective CHO cells. After 24 h, LDL (1,2.5, or 5 pg/mL) was added 
and incubated for 24 h. The amount of apo(a) complexed to LDL was 
measured by ELISA and is expressed as percent of total apo(a) secreted 
into the medium. The results are means f SD of three separate 
experiments. Lecl, lackofglycosyltransferaseT1; Lec2,decreased sialic 
acid addition: Lec8. decreased galactose addition. 
~~ 
association behavior were compared to those of wild-type r-apo- 
(a)-XL. When analyzed by SDS-agarose electrophoresis 
under reducing conditions and immunoblotting, r-apo(a)-Arg 
was indistinguishable from r-apo(a)-XL with regard to 
molecular mass and estimated amounts secreted into the cell 
medium. ELISA results revealed that r-apo(a)-Arg was 
synthesized and secreted at a concentration identical to that 
of r-apo(a)-XL. To study the ability of r-apo(a)-Arg to 
associate with LDL, increasing amounts of freshly prepared 
LDL were added directly to the medium of cos-7 cells 2 and 
16 h after transfection with pSG5-Arg. After 8 h of incubation, 
media were subjected to SDS-agarose electrophoresis and 
immunoblotting as well as density gradient ultracentrifugation 
and the double-antibody DELFIA. When compared to r-apo- 
(a)-XL, r-apo(a)-Arg showed a drastically reduced ability to 
form complexes with LDL (Figure 8). However, between 5% 
and 10% of r-apo(a)-Arg was still found to be associated with 
LDL as determined by densitometric scanning of the gels. 
This indicated a weak interaction between LDL and r-apo- 
(a)-Arg independent of Cys-4057. These results were con- 
firmed by double-antibody DELFIA analyses. Again, between 
5% and 20% of r-apo(a)-Arg was found to be complexed with 
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FIGURE 7: Extracellular complex formation of r-apo(a)-XL with 
LDL after alkylation of free cysteine residues. cos-7 cells were 
transfected with pSG5-XL and the resulting cell medium was used 
in association experiments after treatment with iodoacetamide (for 
details, see Experimental Procedures). Similarly, LDL was also 
modified by iodoacetamide treatment. (1) In a control experiment, 
unmodified medium and unmodified LDL were used in the association 
experiment. (2) Modified LDL was incubated with unmodified 
medium. (3) Modified LDL was incubated with modified medium. 
Incubation conditions were identical as described above and complex 
formation was monitored by double-antibody DELFIA analyses. 
Complex formation in the control mixture was set to 100%. 
r 
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FIGURE 8: Extracellular association of r-apo(a)-Arg (Cys4057 - 
Arg) with LDL. cos-7 cells were transfected with wild-type pSG5- 
XL (WT) or mutated pSG5-Arg (M). In the mutated clone Cys- 
4057 was replaced by Arg using site-directed mutagenesis. LDL 
(5 or 10 pg of protein/mL) was added in two equal aliquots 2 and 
16 h after transfection. Twenty-four hours after transfection the cell 
media were collected and aliquots were subjected to nondenaturing 
SDS-agarose gel electrophoresis. After protein transfer to nitrocel- 
lulose filters, apo(a)-specific bands were visualized using a rabbit 
anti-human apo(a) antiserum (K27 1 )  and an enhanced chemilumi- 
nescent detection system. The positions of free apo(a) and apo(a)- 
apoB complexes are indicated on the right. To estimate the molecular 
sizes of the bands, an apo(a) size standard was included (St) and is 
labeled on the left. 
LDL, although no unpaired Cys residue was present in this 
r-apo( a) species. 
UNoncovalentn Interaction between r-Apo(a)-L and LDL. 
To study the nature of interaction between r-apo(a) and LDL 
independent of the formation of a disulfide bond in more detail, 
complex formation was measured by double-antibody DELFIA 
in the presence of high salt concentrations, detergents, and 
eaminocaproic acid, using wild-type r-apo(a)-XL or its 
mutated homologue r-apo(a)-Arg. The results are displayed 
in Table 4. eAminocaproic acid can completely prevent 
complex formation of r-apo(a)-XL or r-apo(a)-Arg with LDL 
when added at a concentration of 50 mM. However, when 
the inhibitor was added 4 h after the association incubation 
was initiated, already-formed complexes between r-apo(a)- 
XL and LDL were only partly dissociated. In contrast, 
complexes between r-apo(a)-Arg and LDL were sensitive to 
e-aminocaproic acid even after the 4-h preincubation period. 
This suggesting that r-apo(a)-XL bound to LDL by disulfide 
bridges was not sensitive to the treatment with eaminocaproic 
acid, whereas the noncovalent interaction between r-apo(a)- 
Arg and LDL was easily dissociated. High salt concentration 
did not affect complex formation of wild-type or mutant 
r-apo(a) at a sodium chloride concentration of up to 10%. In 
contrast, detergents, both ionic and nonionic, strongly de- 
creased the efficiency of complex formation for both r-apo(a)- 
XL/LDL complexes and r-apo(a)-Arg/LDL complexes. 
DISCUSSION 
Lp(a) is a very atherogenic lipoprotein. The concentration 
of Lp(a) is essentially unaffected by dietary or drug treatment 
(Kostner, 1988). Understanding the biosynthesis of Lp(a) is 
therefore important and may provide the rationale for the 
development of drug intervention protocols to control Lp(a) 
levels in human plasma. We and others have demonstrated 
that Lp(a) plasma levels are determined by the rate of synthesis 
and not by the catabolic rate (Krempler et al., 1983; Rader 
et al., 1993). Recent work by others using transgenic mice 
(Chiesa et al., 1992; Linton et al., 1994) and primary cultures 
of baboon liver cells suggested that Lp(a) assembly may occur 
in the plasma compartment (White et al., 1993). These 
observations were substantiated very recently by studies in 
transfected cells where extracellular interaction of r-apo(a) 
with LDL was reported (Chiesa et al., 1992; Koschinsky et 
al., 1993). Several mechanisms of interaction between apo- 
(a) and LDL were suggested, including ionic interaction 
between apo(a) and apoB as well as the formation of a disulfide 
bond between the apolipoproteins involving Cys-4057 (Sommer 
et al., 1991; Guevara et al., 1993; McLean et al., 1987). Two 
recent studies demonstrated that Cys-4057 is directly involved 
in Lp(a) assembly (Koschinsky et al., 1993; Brunner et al., 
1993). 
In the present study we examined the following questions: 
First, does the number of kringle IV sequences affect the 
synthesis and secretion of apo(a) or its ability to associate 
with LDL? Second, is the presence of kringle IV-36 in r-apo- 
(a) sufficient for r-apo(a)/LDL association? Third, is a single 
free SH group on kringle IV-36 of r-apo(a) necessary for its 
association with apoB? Fourth, how are r-apo(a) synthesis, 
secretion, and complex formation affected by the carbohydrate 
moiety of apo(a)? 
To address these questions, a high-level expression system 
for r-apo(a) was required to facilitate an accurate measurement 
of r-apo(a) in its free form and within r-apo(a)/LDL complexes 
by DELFIA quantitation and Western blotting analysis. To 
achieve this, apo(a) cDNAs of variable length were cloned 
into the eukaryotic expression vector pSG5 and transiently 
transfected into cos-7 cells. “Transferrinfection” (Wagner et 
al., 1990; Zatloukal et al., 1992; Cotten et al., 1992) was 
chosen for the transfection protocol. This procedure relies on 
receptor-mediated DNA uptake via the transferrin or the 
adenovirus receptor of cells. Apo( a) cDNA constructions, a 
polylysine-transferrin conjugate, and the replication-defective 
adenovirus d13 13 form a complex particle that is taken up by 
receptor-mediated endocytosis. After internalization and 
formation of coated vesicles, the adenovirus coat proteins lyse 
the newly formed endosomes. Thus lysosomal degradation of 
the complex is bypassed, resulting in a high copy number of 
plasmids and highly efficient expression of r-apo(a) in the 
cells. 
By this method r-apo(a) was secreted in its glycosylated 
form. Highest rates of r-apo(a) synthesis were observed 
between 24 and 48 h after transfection. ELISA assays using 
a polyclonal coating antiserum and a monoclonal detection 
antibody determined that r-apo(a) molecules with 9, 15, or 
18 kringle IV repeats were expressed at high concentrations. 
The r-apo(a)-S, however, with only three kringle IV sequences, 
was poorly detected by the polyclonal antiserum K27 1. The 
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Table 4: Effect of eAminocaproic Acid, NaC1, SDS, and n-Octyl Glucoside on the Association of r-Apo(a)-XL and r-Apo(a)-Arg with Human 
Plasma LDL 
r-apo(a) found in r-apo(a)-LDL complexes“ (% f SD) 
inhibitor r-apo(a)-XL“ r-apo(a)-Arg“ r-apo(a)-XLb r-apo(a)-Argb 
e-aminocaproic acid none 55  f 2.8 18 f 1.3 55  f 2.8 18 f 0.9 
1 mM 61 f 3.3 13 f 0.6 62 f 3.1 16 f 0.7 
10 mM 24 f 1.1 2 f 0.1 34 h 1.7 6 f 0.3 
50 mM 4 f 0.1 5 f 0.4 23 f 1.1 3 f 0.1 
2% 64 f 4.8 17 f 0.7 
5% 62 f 3.7 13 f 0.3 
10% 59 f 4.4 10 f 0.9 
0.0 1 % 35 f 3.8 5 f 0.3 
0.1% 0 f 0.1 0 f 0.1 
18 f 0.7 0.01% 64 f 4.2 
0.1% 35 f 1.8 7 f 0.3 
NaCl none 64 f 5.3 20 f 0.9 nd nd 
SDS none 64 f 4.0 20 f 0.8 nd nd 
n-octyl glucoside none 64 f 3.6 20 f 1.1 nd nd 
Inhibitor was added at the same time as human plasma LDL to the association mixture. Inhibitor was added 4 h after human plasma LDL was 
added to the association mixture. nd, not determined. 
monoclonal antibody 1A2 did not detect the resulting 
recombinant protein at all, because it is directed against an 
epitope in a “type A” kringle IV repeat not present on 
r-apo(a)-S (Dieplinger et al., submitted for publication). 
Experiments with a monoclonal antibody directed against 
kringle V sequences of apo(a) (Huby et al., 1994) or a new 
polyclonal antiserum (K202) revealed, however, that r- 
apo(a)-S is synthesized and secreted at normal concentrations. 
Apo(a) is a highly glycosylated protein with a high sialic 
acid content. To study the influence of the carbohydrate 
content on the synthesis and secretion of apo(a), CHO cell 
lines with well-characterized glycosylation defects were 
transfected and r-apo(a) production was monitored. The 
antibodies used in this study have been shown to react 
identically to apo(a) species with varying carbohydrate 
contents (H. J. Menzel and G. M. Kostner, personal com- 
munication). The results suggested that sialic acid residues 
on r-apo(a) are not a prerequisite for proper secretion of the 
protein. In fact, transfected cells with a severely decreased 
ability to add sialic acid residues produced about 50% more 
r-apo(a) than transfected cells without such a defect. This 
could be caused by the bypassing of certain glycosylation steps 
and therefore a faster processing of r-apo(a) in the Golgi 
apparatus. In contrast to sialylation, addition of N-acetyl- 
glucosamine by glycosyltransferase T1 in the Golgi compart- 
ment seems to be important for proper secretion since 
transfected cells with a defect in this processing step secreted 
only about half the amount of r-apo(a) as transfected wild 
type cells did. 
r-Apo(a) secreted by transiently transfected normal cos-7 
cells readily associated with LDL when approximately 
equimolar amounts were combined and the mixture was 
incubated at 37 “C. Complex formation was observed when 
LDL was directly added to the medium in the culture plates 
or when it was added to medium that had been removed from 
the cells. However, complex formation was always slightly 
more efficient in the presence of cells. A possible explanation 
for this might be that, in the presenceof cells, once ther-apo(a) 
is secreted, it can immediately associate with LDL. This 
complex formation “in statu nascendi” might protect r-apo(a) 
from modification, e.g., oxidation or degradation. 
The kinetics of association in our experiments differ from 
the data reported by Chiesa et al. (1992). Whereas these 
authors reported that r-apo(a) associated with LDL in the 
order of minutes, it took 0.5-1 h to observe a significant 
accumulation of complexes in our experiments. This dis- 
crepancy remains unexplained but might be caused by a 
difference between the r-apo(a) produced in tissue culture 
versus apo(a) produced in transgenic mice. Another plausible 
explanation is that certain plasma components enhance 
complex formation, as has been reported by Koschinsky et al. 
(1993). 
Complex formation was very efficient at equimolar con- 
centrations of LDL and r-apo(a) when the complexes were 
analyzed in SDS-agarose gel electrophoresis and immuno- 
blotting experiments. Association was observed for r-apo(a) 
molecules with 9, 15, and 18 kringle IV repeats but was 
undetectable in a construction with only three kringle IV 
repeats, despite the fact that the unique kringle containing 
the free cysteine residue (kringle IV-36) was present in this 
construction. These results indicated that the presence of the 
single free cysteine residue on r-apo(a) alone was not sufficient 
for complex formation. To substantiate these results, we 
analyzed additional r-apo(a) variants and demonstrated that 
the region between kringle IV-3 1 and kringle IV-35 is essential 
for complex formation. Replacement of these kringle struc- 
tures by kringle IV-1 through 5 did not result in the ability 
to form complexes with LDL. r-Apo(a) with defects in the 
carbohydrate moiety exhibited similar association properties 
as wild-type r-apo(a), indicating that the negative charge 
contributed by the sialic acid residues does not participate in 
apo(a)-apoB interaction. 
The apo(a)/apoB heterodimers found in native Lp(a) do 
not dissociate upon delipidation. Separation is observed only 
if Lp(a) is incubated with disulfide reducing agents such as 
DTT or P-mercaptoethanol. The same was true in our 
experiments, where complexes dissociated instantly after the 
addition of 5% P-mercaptoethanol, indicating that disulfide 
bridge(s) stabilized the apo(a)/LDL complex. This was 
further substantiated by the finding that alkylation of free 
Cys residues on LDL/apoB or r-apo(a) decreased complex 
formation drastically, again suggesting the formation of a 
disulfide bridge during the association process, as has been 
proposed by many other studies. 
To investigate the proposed role of cysteine residue 4057 
on apo(a) as the site of interaction with LDL, it was replaced 
by arginine, utilizing site-directed mutagenesis. The resulting 
mutated protein, r-apo(a)-Arg, was indistinguishable from 
r-apo(a) with regard to its synthesis, secretion, and im- 
munological reactivity toward all anti-apo(a) antibodies used 
inour laboratories. r-Apo(a)-Arg had a drastically decreased 
affinity to bind to LDL. Similar results were obtained in two 
other studies in which Cys-4057 was replaced by Ser or Gly 
(Koschinsky et al., 1993; Brunner et al., 1993). Small amounts 
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of complexes formed also with the mutant r-apo(a) in our 
study, indicating that in addition to the formation of a disulfide 
bridge, noncovalent binding between r-apo(a) and LDL occurs 
that is independent of Cys-4057. Strong “noncovalent” 
interaction between apo(a) and apoB has been observed earlier 
(Phillips et al., 1992; Kostner & Grillhofer, 1991). To study 
this “noncovalent” interaction in more detail we have per- 
formed association experiments in the presence of different 
potential inhibitors. Whereas e-aminocaproic acid and ionic 
as well as nonionic detergents completely abolished complex 
formation when present in the association experiment, high 
salt concentrations up to 10% NaCl did not inhibit the 
formation of r-apo(a)/LDL complexes. Interestingly, the 
“noncovalent” interaction between r-apo(a)-Arg lacking Cys- 
4057 and LDL was also essentially unaffected by high salt 
concentrations. This suggested the participation of a highly 
specific, salt-stable interaction between apo(a) and LDL in 
the formation of complexes that is independent of Cys-4047. 
We speculate that this interaction between apo(a) and apoB 
on LDL might bring the two -SH groups in such close 
proximity that a disulfide bond can be formed by oxidation. 
This covalent bond, finally, renders the complex stable to 
t-aminocaproic acid and detergents such as SDS. 
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